Newsfeeds - Spark Newswire

4 minute read

Rocket Pharma COO On Observing Rare Disease Day, And Why It Deserves US Attention

February 28, 3:34 PM

Feb. 28 is Rare Disease Day. It's meant to observe the more than 400 million people globally — 50% of them children — that are affected by rare, pediatric life-threatening diseases such as leukemia, Cystic Fibrosis and Hemophilia to name a few.

RCKT

1 minute read

Rocket Pharmaceuticals Q4 EPS $(0.92) Misses $(0.80) Estimate; Cash, Cash Equivalents & Investments Of Approximately $400M With Operational Runway Expected Through 2024

By Benzinga Newsdesk

February 28, 4:21 AM

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.80) by 15 percent. This is a 33.33 percent decrease over losses of $(0.69) per share

RCKT

1 minute read

B of A Securities Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $35

By Benzinga Newsdesk

December 23, 7:29 AM

B of A Securities analyst Greg Harrison maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Buy and lowers the price target from $38 to $35.

RCKT

1 minute read

SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $50

By Benzinga Newsdesk

December 22, 3:46 PM

SVB Leerink analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $54 to $50.

RCKT

4 minute read

Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

December 22, 2:13 PM

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

$APE

3 minute read

Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher

By Lisa Levin

December 22, 1:28 PM

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday.

EVK

3 minute read

Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3

By Lisa Levin

December 22, 11:13 AM

U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday.

CEI

2 minute read

Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting

By Charles Gross

December 22, 7:04 AM

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today announces updates from the Company's end-of-Phase 1 meeting with the U.S.

RCKT

2 minute read

Analyst Ratings

Expert Ratings for Rocket Pharmaceuticals

By Benzinga Insights

December 6, 4:03 PM

Rocket Pharmaceuticals (NASDAQ:RCKT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

RCKT